Schabacker Matthew 4/A

4/A · CONMED Corp · Filed Mar 18, 2026

AI-generated summary of this filing

Updated Mar 18, 2026

CONMED (CNMD) VP Matthew Schabacker Receives 17,471 RSUs

What Happened

Matthew Schabacker, VP GM Advanced Surgical at CONMED (CNMD), received a grant of 17,471 restricted stock units (RSUs) on 2026-03-02. The filing shows an acquisition of 17,471 derivative shares at $0.00 per share (RSUs are awards, not purchases), with no immediate cash paid or proceeds received.

Key Details

Transaction type: Award/Grant (code A) — restricted stock units (derivative).
Date of grant: 2026-03-02; Form 4 amended on 2026-03-18 to correct the amount.
Price: $0.00 per RSU (typical for RSU awards); reported aggregate value shown as $0.
Correction note: This Form 4/A increases the originally reported 9,827 RSUs by a special award of 7,644 RSUs for a total of 17,471 RSUs.
Vesting: RSUs are subject to the Company’s 2025 Long-Term Incentive Plan and generally vest over three years (33% at year 1, 33% at year 2, 34% at year 3).
Shares owned after transaction: Not specified in this filing.

Context

These RSUs are a compensation award (not a market purchase or sale). They represent a contingent right to receive one share per RSU upon vesting and do not by themselves indicate buying or selling intent. The amendment was filed to correct the grant quantity, ensuring public records reflect the full 17,471-RSU award.

Form 4/AAmended

Period: 2026-03-02

VP GM Advanced Surgical

Transactions

Award
RSUs (Restricted Stock Units)
[F1][F2]
2026-03-02+17,471→ 17,471 total
Exercise: $0.00Exp: 2036-03-02→ Common Stock (17,471 underlying)

Footnotes (2)

[F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.
[F2]This Form 4/A is filed solely to correct the amount of RSUs granted. A special award of 7,644 shares was awarded in addition to the originally reported 9,827 shares for a total of 17,471 RSUs granted.

Signature

/s/ Thomas Fistek for Matthew Schabacker by Power of Attorney|2026-03-18

1 file